Corient Capital Partners’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$303K	Hold	21,574	–	–	0.02%	459
2022 Q2	$303K	Sell	21,574 -627	-3%	-$8.81K	0.02%	472
2022 Q1	$318K	Buy	22,201 +2,599	+13%	+$37.2K	0.02%	517
2021 Q4	$267K	Buy	19,602 +1,903	+11%	+$25.9K	0.02%	563
2021 Q3	$290K	Buy	+17,699	New	+$290K	0.02%	505